Related Experiment Videos
Are there different ETB receptors mediating constriction and relaxation?
Journal of Cardiovascular Pharmacology
|January 1, 1995
Summary
Endothelin ETB receptor antagonists block ET-1-mediated dilation but not constriction. This study reveals cross-talk between ETA and ETB receptors, suggesting a single ETB receptor subtype mediates both constriction and dilation.
Area of Science:
- Pharmacology
- Molecular Biology
- Physiology
Background:
- Endothelin (ET) ETB receptors are implicated in vascular tone.
- Previous studies suggested distinct ETB receptor subtypes mediating dilation and constriction.
- Selective ETB receptor antagonists failed to inhibit ET-1-mediated constriction.
Purpose of the Study:
- To investigate the functional antagonism of ETB-mediated constriction by ETB receptor antagonists.
- To explore the potential existence of two ETB receptor subtypes.
Main Methods:
- Experiments conducted on rat tracheal rings.
- Utilized selective ETB receptor antagonist Ro 46-8443.
- Employing ETA receptor antagonist BQ-123 and sarafotoxin S6c for receptor desensitization.
Main Results:
- Ro 46-8443 antagonized sarafotoxin S6c-induced contractions but not ET-1-induced contractions.
- ET-1-mediated contractions were primarily ETB receptor-dependent.
- Blocking ETA receptors with BQ-123 revealed ETB receptor antagonist effects on ET-1-mediated contractions.
Conclusions:
- ET-1 and sarafotoxin S6c activate a common ETB receptor on rat tracheal rings.
- Cross-talk between ETA and ETB receptors allows ETA to compensate for ETB receptor blockade.
- The findings challenge the notion of distinct endothelial and smooth muscle ETB receptor subtypes.